OM OUTSET MED INC revenue, earnings and financials

For the quarter ended June 30, 2026, OUTSET MED INC reported revenue of $31.6M (up 0.7% from a year earlier), net income of −$18.0M and diluted EPS of −$0.97; over the last four quarters revenue was $118M and net income −$74.3M; for the fiscal year ended December 2025 revenue was $119M, up 5.1% on the year before.

OM annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $119M, gross profit $46.8M, operating income −$66.7M, net income −$81.7M (margin -68.3%), EPS −$5.37
• Fiscal year ended Dec 2024: revenue $114M, gross profit $38.6M, operating income −$113M, net income −$128M (margin -112.6%), EPS −$36.96
• Fiscal year ended Dec 2023: revenue $130M, gross profit $29.0M, operating income −$170M, net income −$173M (margin -132.5%), EPS −$52.28
• Fiscal year ended Dec 2022: revenue $115M, gross profit $17.8M, operating income −$161M, net income −$163M (margin -141.2%), EPS −$3.38
• Fiscal year ended Dec 2021: revenue $103M, gross profit $7.61M, operating income −$131M, net income −$132M (margin -128.6%), EPS −$2.89

OM quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $31.6M (up 0.7% year over year), net income −$18.0M, EPS −$0.97
• Quarter ended Mar 31, 2026: revenue $27.9M (down 6.3% year over year), net income −$19.0M, EPS −$1.03
• Quarter ended Dec 31, 2025 (from the annual report): revenue $28.9M (down 2.0% year over year), net income −$19.5M, EPS $0.33
• Quarter ended Sep 30, 2025: revenue $29.4M (up 2.7% year over year), net income −$17.8M, EPS −$1.00
• Quarter ended Jun 30, 2025: revenue $31.4M (up 14.7% year over year), net income −$18.5M, EPS −$1.04
• Quarter ended Mar 31, 2025: revenue $29.8M (up 5.6% year over year), net income −$25.8M, EPS −$3.66
• Quarter ended Dec 31, 2024 (from the annual report): revenue $29.5M (down 3.4% year over year), net income −$25.6M, EPS −$7.21
• Quarter ended Sep 30, 2024: revenue $28.7M (down 5.6% year over year), net income −$27.9M, EPS −$8.02
• Quarter ended Jun 30, 2024: revenue $27.4M (down 24.0% year over year), net income −$34.5M, EPS −$9.96
• Quarter ended Mar 31, 2024: revenue $28.2M (down 15.8% year over year), net income −$39.9M, EPS −$11.77
• Quarter ended Dec 31, 2023 (from the annual report): revenue $30.5M (down 4.7% year over year), net income −$38.6M, EPS −$49.55
• Quarter ended Sep 30, 2023: revenue $30.4M (up 9.4% year over year), net income −$46.2M, EPS −$0.93
• Quarter ended Jun 30, 2023: revenue $36.0M (up 43.8% year over year), net income −$44.0M, EPS −$0.90
• Quarter ended Mar 31, 2023: revenue $33.5M (up 9.5% year over year), net income −$44.0M, EPS −$0.90
• Quarter ended Dec 31, 2022 (from the annual report): revenue $32.0M (up 13.7% year over year), net income −$41.4M, EPS −$0.83
• Quarter ended Sep 30, 2022: revenue $27.8M (up 5.5% year over year), net income −$40.8M, EPS −$0.85
• Quarter ended Jun 30, 2022: revenue $25.1M (down 0.6% year over year), net income −$43.8M, EPS −$0.92
• Quarter ended Mar 31, 2022: revenue $30.6M (up 33.3% year over year), net income −$36.9M, EPS −$0.78
• Quarter ended Dec 31, 2021 (from the annual report): revenue $28.2M, net income −$41.2M, EPS −$0.88
• Quarter ended Sep 30, 2021: revenue $26.3M, net income −$30.5M, EPS −$0.65

OM cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow −$46.3M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow −$116M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow −$131M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow −$146M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow −$130M, share buybacks n/a

OM balance sheet

• Jun 30, 2026: cash $35.0M, total assets $242M, total liabilities $146M, shareholders' equity $96.3M, long-term debt $97.6M
• Mar 31, 2026: cash $30.6M, total assets $249M, total liabilities $138M, shareholders' equity $112M, long-term debt $96.9M
• Dec 31, 2025: cash $35.0M, total assets $264M, total liabilities $138M, shareholders' equity $127M, long-term debt $96.2M
• Sep 30, 2025: cash $36.4M, total assets $277M, total liabilities $135M, shareholders' equity $142M, long-term debt $95.5M
• Jun 30, 2025: cash $39.6M, total assets $289M, total liabilities $134M, shareholders' equity $155M, long-term debt $94.8M
• Mar 31, 2025: cash $75.9M, total assets $301M, total liabilities $131M, shareholders' equity $170M, long-term debt $94.1M
• Dec 31, 2024: cash $124M, total assets $276M, total liabilities $249M, shareholders' equity $26.8M, long-term debt $197M
• Sep 30, 2024: cash $33.3M, total assets $293M, total liabilities $245M, shareholders' equity $47.8M, long-term debt $197M

What is OM's revenue?

OUTSET MED INC reported $118M of revenue over its last four quarters, through June 30, 2026.

Is OM profitable?

No. OUTSET MED INC lost $74.3M over the last four quarters.

What is OM's EPS?

Diluted earnings per share over the last four quarters were −$2.67; −$0.97 in the latest quarter.

OM ownership and insider trades · All stocks